UNSPSC 51372033: Morphine methylbromide

This classification denotes an opiate C18H22NO3.Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1A51P5NGGU, chemically known as morphinanium, 7,8-didehydro-4,5-epoxy-3,6-dihydroxy-17,17-dimethyl-, bromide, (5.alpha.,6.alpha.)-, but more generally known as morphine methylbromide, which bears US NIH Compound Identifier 5362445. Most nations, for tariff and trade purposes, schedule morphine methylbromide under HS 29391100 and SITC 54141. As of Q4 2014, MORPHINE METHYLBROMIDE remains US FDA's Preferred Term for this commodity.

SMILES: C[N+]1(CC[C@]23C4C5CCC(C4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)O)O)C.[BR-].

UNSPSC 51372033 Morphine methylbromide is a Commodity code that does not align with recent state and local procurement activity in the available record. The single posted opportunity tagged under this code—Seminole County, Florida's IFB60459723LAS for naloxone and drug deactivation systems—procures naloxone (an opioid antagonist used in overdose response) and deactivation equipment for community health support, not morphine methylbromide (a morphine derivative used in pharmaceutical synthesis and research). The scope mismatch suggests either a data-entry error in the original solicitation tagging or a categorical misalignment between the code's nominal pharmaceutical scope and what state and local buyers are actually sourcing under it.

Seminole County issued the only recent opportunity in the block, an IFB posted June 30, 2026, with a response deadline of July 26, 2023 (a date that has passed). The procurement calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. No other states or municipalities appear in the recent-opportunities record, and no established pattern of repeat buying under this code emerges from the source. The absence of additional opportunities and the categorical disconnect between the code's pharmaceutical label and the actual goods being purchased suggest limited current activity in state and local procurement under this Commodity code.